Paromomycin: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Drugs" to "Category:Pharmacology") |
Neil.m.young (talk | contribs) (Text replacement - " w/ " to " with ") |
||
Line 8: | Line 8: | ||
===Intestinal [[amebiasis]]=== | ===Intestinal [[amebiasis]]=== | ||
*25-35 mg/kg/day PO divided tid x5-10 days | *25-35 mg/kg/day PO divided tid x5-10 days | ||
**Give | **Give with food | ||
===[[Hepatic encephalopathy]]=== | ===[[Hepatic encephalopathy]]=== | ||
*adjunct tx: 1000 mg PO qid x5-6 days | *adjunct tx: 1000 mg PO qid x5-6 days | ||
**Give | **Give with food | ||
==Pediatric Dosing== | ==Pediatric Dosing== |
Revision as of 21:47, 11 July 2016
Administration
- Type: Amebicide
- Dosage Forms: 250
- Routes of Administration: Oral
- Common Trade Names: Humatin
Adult Dosing
Intestinal amebiasis
- 25-35 mg/kg/day PO divided tid x5-10 days
- Give with food
Hepatic encephalopathy
- adjunct tx: 1000 mg PO qid x5-6 days
- Give with food
Pediatric Dosing
Intestinal amebiasis
- 25-35 mg/kg/day PO divided tid x5-10 days
Special Populations
- Poorly absorbed when given orally
- Use during pregnancy has limited data
Renal Dosing
- No change in dosing
Hepatic Dosing
- No change in dosing
Contraindications
- Allergy to class/drug
- GI obstruction
- caution if ulcerative colitis
- caution if inflammatory bowel dz
- caution if renal impairment
Adverse Reactions
Serious
- nephrotoxicity
- ototoxicity, auditory
- ototoxicity, vestibular
- neurotoxicity
- neuromuscular blockade
- malabsorption syndrome (prolonged use)
- superinfection (prolonged use)
- enterocolitis
Common
Pharmacology
- Half-life: Unknown
- Metabolism: CYP450
- Excretion: Feces
Mechanism of Action
Bactericidal and amebicidal. Paromomycin binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis; it suppresses urease producing bacteria, reducing ammonia absorption from gut
Comments
See Also
References
UpToDate, Epocrates